Why BioCryst Pharmaceuticals Stock Is Falling Today

Prosper Junior Bakiny, The Motley Fool
·2-min read
Why BioCryst Pharmaceuticals Stock Is Falling Today

BioCryst Pharmaceuticals (NASDAQ: BCRX) stock is dropping sharply on Thursday after the biotech company reported disappointing fourth-quarter financial results. BioCryst's shares were down by 8.4% as of 1:53 p.m. EST. BioCryst's total revenue for the fourth quarter ending Dec. 31 was roughly $4 million, down from the $39.7 million in revenue recorded during the year-ago period.